Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Titel:
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
Auteur:
Munro, Alasdair P S Janani, Leila Cornelius, Victoria Aley, Parvinder K Babbage, Gavin Baxter, David Bula, Marcin Cathie, Katrina Chatterjee, Krishna Dodd, Kate Enever, Yvanne Gokani, Karishma Goodman, Anna L Green, Christopher A Harndahl, Linda Haughney, John Hicks, Alexander van der Klaauw, Agatha A Kwok, Jonathan Lambe, Teresa Libri, Vincenzo Llewelyn, Martin J McGregor, Alastair C Minassian, Angela M Moore, Patrick Mughal, Mehmood Mujadidi, Yama F Murira, Jennifer Osanlou, Orod Osanlou, Rostam Owens, Daniel R Pacurar, Mihaela Palfreeman, Adrian Pan, Daniel Rampling, Tommy Regan, Karen Saich, Stephen Salkeld, Jo Saralaya, Dinesh Sharma, Sunil Sheridan, Ray Sturdy, Ann Thomson, Emma C Todd, Shirley Twelves, Chris Read, Robert C Charlton, Sue Hallis, Bassam Ramsay, Mary Andrews, Nick Nguyen-Van-Tam, Jonathan S Snape, Matthew D Liu, Xinxue Faust, Saul N
Verschenen in:
Lancet
Paginering:
Jaargang 398 () nr. 10318 pagina's 2258-2276
Jaar:
2021
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.